![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Senate Vote Planned on Federal Right-to-Try Bill
Senate Vote Planned on Federal Right-to-Try Bill
![](https://www.fdanews.com/ext/resources/test/Drug-Images3/gavel.gif?t=1433929221&width=430)
September 28, 2016
The Senate is considering a bill that would prohibit the federal government from restricting the sale and use of experimental, unapproved drugs for fatal illnesses.
Known as a right-to-try law, similar bills have been passed in 31 states that allow terminally ill patients earlier access to drugs in clinical trials.
An FDA official testified before a Senate panel on the agency’s expanded access programs. Representatives from state governments that have considered such laws, as well as patient advocates and the CEO of a pharmaceutical company, also testified.
Upcoming Events
-
21Oct